RNA Therapy
The RNA industry is booming with 1350+ key drug developers advancing the discovery through development of efficacious and safe RNA vaccines, therapeutics, and genetic medicines to positively impact patient health.
Our mission is to be the thought-leading platform to provide a roadmap to accelerate RNA platforms, technologies and innovations with optimal design, targeted delivery and manufacturing at scale to achieve clinical validation and commercial success for applications across oncology, rare and infectious diseases and beyond.
Delivering Safe & Effective RNA Therapies & Vaccines to Patients Faster
Turbocharging a new wave of activity, the RNA industry is at an inflexion point, with RNAi gaining further approvals, mRNA cancer vaccines advancing through the clinic and RNA editors increasing investment interest. From delivery to manufacturing innovations, pre-clinical translation to clinical trial success, RNA continues to unleash its potential to improve the patient outcomes for a wide range of diseases.
From hyper-relevent and niche industry dedicated conferences, RNA-specific clinical trial and drug data and knowledge sharing and problem-solving expert networks, we provide a diverse set of opportunities to stay up to date with scientific advancements, solve shared challenges and gain the clarity of insight you need to accelerate the development of RNA-based medicines to patients faster.
Featured RNA Therapy Products
Beacon
Conferences
Intelligence
RNA Therapy Products by Type
Make Faster, Better Drug Development Decisions
Premium Insight and Meaningful Connections for Biopharma
Expert-driven, Life Science Market Intelligence Solutions
CONTACT US
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - RNA Therapy
"*" indicates required fields